HealthCor Management, L.P.
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Dec 31, 2022, never from the firm's own description.
Closest benchmark: the Nasdaq-100 as of 2022-12-31, active share 98.7%; sector active share 83.4% against the combined 13F book's sector weights.
Over time 12 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
18 tracked positions · as of Dec 31, 2022 · Δ vs Sep 30, 2022Portfolio Trend
Sector Breakdown
As of Dec 31, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 97.3% | $103,712,003 |
| Unclassified | 2.7% | $2,851,050 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GERN | Geron Corp | −1,404,234 | 500,000 | $1,210,000 | |
| — | −1,150,000 | 150,000 | $744,000 | ||
| SNDX | Syndax Pharmaceuticals Inc | −789,240 | 70,000 | $1,781,500 | |
| RCKT | Rocket Pharmaceuticals, Inc. | −395,140 | 50,000 | $978,500 | |
| BMRN | Biomarin Pharmaceutical Inc | −391,273 | 367,765 | $38,059,999 | |
| CYTK | Cytokinetics Inc | −270,120 | 164,440 | $7,534,640 | |
| — | −206,830 | 60,000 | $0 | ||
| ALKS | Alkermes plc. | −193,500 | 110,000 | $2,874,300 | |
| — | −74,600 | 30,000 | $1,314,300 | ||
| INSP | Inspire Medical Systems, Inc. | −34,740 | 3,500 | $881,580 | |
| NBIX | Neurocrine Biosciences Inc | −1,720 | 20,000 | $2,388,800 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterSold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABBV | AbbVie Inc. | 310,250 | $41,638,652 | |
| A | Agilent Technologies, Inc. | 338,030 | $41,087,546 | |
| BSX | Boston Scientific Corp | 958,600 | $37,126,578 | |
| LLY | ELI LILLY & Co | 103,150 | $33,353,552 | |
| COR | Cencora, Inc. | 239,150 | $32,364,169 | |
| UNH | Unitedhealth Group Inc | 62,980 | $31,807,419 | |
| DHR | Danaher Corp | 117,800 | $30,426,562 | |
| THC | Tenet Healthcare Corp | 518,990 | $26,769,504 | |
| TMO | Thermo Fisher Scientific Inc. | 51,240 | $25,988,415 | |
| CNC | Centene Corp | 300,970 | $23,418,475 | |
| CI | Cigna Group | 76,910 | $21,340,217 | |
| HUM | Humana Inc | 42,920 | $20,824,354 | |
| BIIB | Biogen Inc. | 69,950 | $18,676,650 | |
| ELV | Elevance Health, Inc. | 38,910 | $17,674,478 | |
| AMGN | Amgen Inc | 75,370 | $16,988,398 | |
| LIVN | LivaNova PLC | 328,030 | $16,654,083 | |
| HSIC | Henry Schein Inc | 248,920 | $16,371,468 | |
| BMY | Bristol Myers Squibb Co | 223,150 | $15,863,733 | |
| INCY | Incyte Corp | 227,851 | $15,183,990 | |
| — | 229,530 | $14,206,000 | ||
| BDX | Becton Dickinson & Co | 62,930 | $14,022,690 | |
| — | 1,607,650 | $13,842,000 | ||
| CVS | CVS HEALTH Corp | 131,150 | $12,507,775 | |
| MCK | Mckesson Corp | 35,040 | $11,909,044 | |
| ABT | Abbott Laboratories | 98,970 | $9,576,337 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 367,765 | $38,059,999 | 35.72% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 321,380 | $36,393,071 | 34.15% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 164,440 | $7,534,640 | 7.07% | |
| ACRV |
Acrivon Therapeutics, Inc.
Healthcare
|
NEW | 284,201 | $3,273,995 | 3.07% | |
| HYPR |
Hyperfine, Inc.
Healthcare
|
Added | 3,880,900 | $3,259,956 | 3.06% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 110,000 | $2,874,300 | 2.70% | |
| CNMD |
CONMED Corp
Healthcare
|
NEW | 27,500 | $2,437,600 | 2.29% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 20,000 | $2,388,800 | 2.24% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 70,000 | $1,781,500 | 1.67% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
NEW | 5,750 | $1,525,762 | 1.43% | |
|
|
Reduced | 30,000 | $1,314,300 | 1.23% | ||
| GERN |
Geron Corp
Healthcare
|
Reduced | 500,000 | $1,210,000 | 1.14% | |
| PEN |
Penumbra Inc
Healthcare
|
NEW | 5,000 | $1,112,300 | 1.04% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Reduced | 50,000 | $978,500 | 0.92% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Reduced | 3,500 | $881,580 | 0.83% | |
|
|
NEW | 15,000 | $792,750 | 0.74% | ||
|
|
Reduced | 150,000 | $744,000 | 0.70% | ||
|
|
Reduced | 60,000 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.